Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mokdad Mezna

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Chemistry & Biology|May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitorsCampbell McInnes, Shudong Wang, Sian Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitorsShudong Wang, Gavin Wood, Christopher Meades, et al.
Cell Communication and Signaling : CCS|October 8, 2014
A novel small-molecule MRCK inhibitor blocks cancer cell invasionMathieu Unbekandt, Daniel R Croft, Diane Crighton, et al.
Journal of Medicinal Chemistry|March 19, 2004
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activityShudong Wang, Christopher Meades, Gavin Wood, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Cancer Discovery|March 4, 2018
Colorectal Tumors Require NUAK1 for Protection from Oxidative StressJennifer Port, Nathiya Muthalagu, Meera Raja, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Cancer Research|October 4, 2018
A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in GlioblastomaJoanna L Birch, Karen Strathdee, Lesley Gilmour, et al.
Cancer Research|February 1, 2018
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin CancerMathieu Unbekandt, Simone Belshaw, Justin Bower, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Chemistry & Biology|May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitorsCampbell McInnes, Shudong Wang, Sian Anderson, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitorsShudong Wang, Gavin Wood, Christopher Meades, et al.
Cell Communication and Signaling : CCS|October 8, 2014
A novel small-molecule MRCK inhibitor blocks cancer cell invasionMathieu Unbekandt, Daniel R Croft, Diane Crighton, et al.
Journal of Medicinal Chemistry|March 19, 2004
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activityShudong Wang, Christopher Meades, Gavin Wood, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2019
Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agentsStuart Francis, Daniel Croft, Alexander W Schüttelkopf, et al.
Cancer Discovery|March 4, 2018
Colorectal Tumors Require NUAK1 for Protection from Oxidative StressJennifer Port, Nathiya Muthalagu, Meera Raja, et al.
Journal of Medicinal Chemistry|May 14, 2010
Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitorsShudong Wang, Carol A Midgley, Frederic Scaërou, et al.
Chemistry & Biology|November 2, 2010
Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agentsShudong Wang, Gary Griffiths, Carol A Midgley, et al.
Cancer Research|October 4, 2018
A Novel Small-Molecule Inhibitor of MRCK Prevents Radiation-Driven Invasion in GlioblastomaJoanna L Birch, Karen Strathdee, Lesley Gilmour, et al.
Cancer Research|February 1, 2018
Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin CancerMathieu Unbekandt, Simone Belshaw, Justin Bower, et al.
Pageof 3